Abstract
The method of reimbursement provides a fair and affordable high-quality health care. The aim of this review is to compare the reimbursement policies in the Netherlands and Bulgaria. The topics discussed are the authorities and considerations in decision-making for the inclusion of medicines in the positive reimbursement list, the pricing of these drugs, as well as the transparency in decision-making for reimbursement.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
